1. Home
  2. PTIX vs LIPO Comparison

PTIX vs LIPO Comparison

Compare PTIX & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • LIPO
  • Stock Information
  • Founded
  • PTIX 1994
  • LIPO 2005
  • Country
  • PTIX United States
  • LIPO United States
  • Employees
  • PTIX N/A
  • LIPO N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • LIPO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTIX Health Care
  • LIPO Health Care
  • Exchange
  • PTIX Nasdaq
  • LIPO Nasdaq
  • Market Cap
  • PTIX 3.7M
  • LIPO 3.5M
  • IPO Year
  • PTIX 2016
  • LIPO 2022
  • Fundamental
  • Price
  • PTIX $0.70
  • LIPO $2.66
  • Analyst Decision
  • PTIX
  • LIPO Strong Buy
  • Analyst Count
  • PTIX 0
  • LIPO 1
  • Target Price
  • PTIX N/A
  • LIPO $16.00
  • AVG Volume (30 Days)
  • PTIX 258.9K
  • LIPO 170.7K
  • Earning Date
  • PTIX 11-14-2024
  • LIPO 11-14-2024
  • Dividend Yield
  • PTIX N/A
  • LIPO N/A
  • EPS Growth
  • PTIX N/A
  • LIPO N/A
  • EPS
  • PTIX N/A
  • LIPO N/A
  • Revenue
  • PTIX N/A
  • LIPO $483,533.00
  • Revenue This Year
  • PTIX N/A
  • LIPO N/A
  • Revenue Next Year
  • PTIX N/A
  • LIPO N/A
  • P/E Ratio
  • PTIX N/A
  • LIPO N/A
  • Revenue Growth
  • PTIX N/A
  • LIPO 0.78
  • 52 Week Low
  • PTIX $0.45
  • LIPO $2.21
  • 52 Week High
  • PTIX $1.87
  • LIPO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 55.96
  • LIPO 45.43
  • Support Level
  • PTIX $0.50
  • LIPO $2.53
  • Resistance Level
  • PTIX $0.56
  • LIPO $2.79
  • Average True Range (ATR)
  • PTIX 0.06
  • LIPO 0.29
  • MACD
  • PTIX 0.01
  • LIPO -0.01
  • Stochastic Oscillator
  • PTIX 84.31
  • LIPO 12.62

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About LIPO Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Share on Social Networks: